Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ADC Therapeutics SAADCT · Entity 6502 | Director | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ADC Therapeutics SA
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 263,344 |
Ending reported balance
After 2026-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-01 · Grant · Acquired 45,000 · Balance 265,500 F1: Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Row 2 · 2026-06-03 · Tax withholding · Disposed 2,156 · Balance 263,344 F2: Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 3, 2026 17:02 UTC | ADC Therapeutics SA ADCT · Entity 6502 | Tax withholdingCommon Shares | 2,156 | $3.08 | $6,640.48 |
DisclosureSEC source: 0001628280-26-040489 · wk-form4_1780520554.xml · nonDerivative · entry 2 Hug Peter · CIK 0002000702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,344 F2 · kind: Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 17:02 UTC | ADC Therapeutics SA ADCT · Entity 6502 | GrantCommon Shares | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040489 · wk-form4_1780520554.xml · nonDerivative · entry 1 Hug Peter · CIK 0002000702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,500 F1 · shares: Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 17:01 UTC | ADC Therapeutics SA ADCT · Entity 6502 | Tax withholdingCommon Shares | 2,144 | $3.58 | $7,675.52 |
DisclosureSEC source: 0001628280-25-031892 · wk-form4_1750194089.xml · nonDerivative · entry 1 Hug Peter · CIK 0002000702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,500 F1 · kind: Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 17:08 UTC | ADC Therapeutics SA ADCT · Entity 6502 | GrantCommon Shares | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029733 · wk-form4_1749157641.xml · nonDerivative · entry 1 Hug Peter · CIK 0002000702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,644 F1 · shares: Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 21:41 UTC | ADC Therapeutics SA ADCT · Entity 6502 | SaleCommon Shares | 1,193 | $2.89 | $3,447.77 |
DisclosureSEC source: 0001628280-24-028991 · wk-form4_1718761304.xml · nonDerivative · entry 1 Hug Peter · CIK 0002000702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,644 F1 · kind: Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 17:40 UTC | ADC Therapeutics SA ADCT · Entity 6502 | GrantCommon Shares | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-028353 · wk-form4_1718401227.xml · nonDerivative · entry 1 Hug Peter · CIK 0002000702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,837 F1 · shares: Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.